[{"id":"f77d9cea-50f0-4134-ad94-b3aac597f423","acronym":"","url":"https://clinicaltrials.gov/study/NCT05709574","created_at":"2024-03-18T14:22:00.111Z","updated_at":"2024-07-02T16:35:14.329Z","phase":"Phase 2","brief_title":"Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer","source_id_and_acronym":"NCT05709574","lead_sponsor":"University of Arizona","biomarkers":" TLR9 • CDX2 • MIR30B","pipe":" | ","alterations":" TLR9 expression","tags":["TLR9 • CDX2 • MIR30B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TLR9 expression"],"overall_status":"Recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 04/20/2023","start_date":" 04/20/2023","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 05/01/2025","study_completion_date":" 05/01/2025","last_update_posted":"2024-03-18"}]